SEC Filing Summary: Hexindai Inc. (Form 6-K)
Business Context and Reporting Period
This Form 6-K was filed by Hexindai Inc., a foreign private issuer, for the month of November 2018. The filing was signed by Zhang Qisen (Johnson), Chief Financial Officer, on November 26, 2018. The registrant's principal executive office is located in Beijing, People's Republic of China. The filing serves to distribute specific corporate documents rather than a full financial report.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural filing containing an exhibit index and does not include financial statements or performance data.
Material Changes
No material changes to financial performance or operations are reported in this filing. The document lists the following exhibits:
- Exhibit 99.1: Press Release
- Exhibit 99.2: Notice of the Annual General Meeting and Proxy Statement
- Exhibit 99.3: Proxy Card for the Annual General Meeting
Guidance, Outlook, and Risks
The filing text does not provide specific guidance, outlook, management commentary, risks, contingencies, or unusual items. These details may be contained within the referenced exhibits (specifically the Press Release or Proxy Statement), but the text of the Form 6-K itself does not summarize them.
Key Facts for Investor Verification
- Verify the content of the attached Press Release (Exhibit 99.1) for any material announcements.
- Review the Notice of the Annual General Meeting (Exhibit 99.2) for upcoming shareholder votes and corporate governance matters.
- Confirm that the registrant is Hexindai Inc., noting the discrepancy with the "Akso Health Group" name in the request metadata.
- Check the date of the Annual General Meeting referenced in the exhibits to ensure timely participation.